NewsPharmaceutical
Trending

Xerostomia Therapeutics Market 2019 Dominating Players Like Acacia Pharma Limited, Colgate-Palmolive, Church & Dwight Co., Inc., GSK, Hikma Pharmaceuticals, Lupin Pharmaceuticals, PENDOPHARM, Pfizer, SUN PHARMA

Global Xerostomia Therapeutics Market

The Global Xerostomia Therapeutics Market is expected to rise from its initial estimated value of USD 648.94 billion in 2018 to an estimated value of USD 874.55 billion by 2026 registering a CAGR of 3.8% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising geriatric population over the world and prevalence of demand of arthroscopy in these populations.

Request For Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-xerostomia-therapeutics-market

Market Definition: Global Xerostomia Therapeutics Market

Xerostomia is a disease leading to oral dryness and are not easily diagnosed. Dryness of mouth is associated with the altered salivary gland functionality and other etiologies causing oral issues. Xerostomia caused due to the absence of saliva flow, and this is due to shrinkage of salivary gland. The xerostomia therapeutics helps to treat these symptoms associated with the dry mouth. The dry mouth symptoms impacts the life style quality of the patient and causes difficulty in the swallowing, chewing and speaking which can lead to the thick oral mucus, sleep disturbance and bad breathing.

Key Developments in the Market:

  • In October 2018, Synedgen Incand the subsidiary Prisyna, announced the launch of Moisyn for the treatment of xerostomia dry mouth.
  • May 2018, Synedgen Inc. and the subsidiary Prisyna , received 510(k) clearance from the US Food and Drug Administration (FDA) to market its family of Moisyn products designed to treat xerostomia. The clearance of the drug from FDA will help the company to provide the Moisyn products to the patients for the treatment and can alleviate the dry mouth symptoms.

Market Drivers:

  • Rising geriatric population has increased the demand for these therapeutics as the elderly population have more symptoms of dry mouth
  • Increase in use of prescription medications

Market Restraints:

  • High cost of xerostomia therapeutics is acting as a major restraint for the market
  • Lack of awareness of xerostomia in the developing and underdeveloped economies

Reasons to Purchase this Report:

  • Current and future of global xerostomia therapeutics market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Want Full Report? Enquire Here @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-xerostomia-therapeutics-market

Segmentation:  Global Xerostomia Therapeutics Market

By Type

  • Salivary Stimulants
  • Salivary Substitutes
  • Dentifrices

By Prescription Based

  • OTC
  • Prescribed

By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

Competitive Analysis:  Global Xerostomia Therapeutics Market

The global xerostomia therapeutics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of xerostomia therapeutics market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Xerostomia Therapeutics Market

Few of the major market competitors currently working in the xerostomia therapeutics market are

  • Acacia Pharma Group PLC,
  • Colgate-Palmolive,
  • Church & Dwight Co. Inc.,
  • GlaxoSmithKline PLC,
  • Hikma Pharmaceuticals PLC,
  • Lupin,
  • OraCoat,
  • Parnell Pharmaceuticals Inc.,
  • Pendopharm,
  • Pfizer Inc.,
  • Sun Pharmaceutical Industries Ltd,
  • Synedgen Inc.

Browse Complete Report @ https://databridgemarketresearch.com/reports/global-xerostomia-therapeutics-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

Tags
Show More
Close
Close